nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R2—digestive system—systemic scleroderma	0.0158	0.124	CbGeAlD
Isoprenaline—PIK3R3—tendon—systemic scleroderma	0.0102	0.0804	CbGeAlD
Isoprenaline—ADRB3—connective tissue—systemic scleroderma	0.00899	0.0707	CbGeAlD
Isoprenaline—PIK3R3—lung—systemic scleroderma	0.00896	0.0705	CbGeAlD
Isoprenaline—PIK3R1—tendon—systemic scleroderma	0.00873	0.0687	CbGeAlD
Isoprenaline—MAPK1—connective tissue—systemic scleroderma	0.00866	0.0681	CbGeAlD
Isoprenaline—ADRBK1—smooth muscle tissue—systemic scleroderma	0.00803	0.0632	CbGeAlD
Isoprenaline—MAPK1—smooth muscle tissue—systemic scleroderma	0.00792	0.0623	CbGeAlD
Isoprenaline—MAPK1—skin of body—systemic scleroderma	0.00782	0.0615	CbGeAlD
Isoprenaline—PIK3R1—lung—systemic scleroderma	0.00766	0.0603	CbGeAlD
Isoprenaline—ADRBK1—digestive system—systemic scleroderma	0.00634	0.0499	CbGeAlD
Isoprenaline—Pallor—Captopril—systemic scleroderma	0.00634	0.0234	CcSEcCtD
Isoprenaline—MAPK1—digestive system—systemic scleroderma	0.00625	0.0492	CbGeAlD
Isoprenaline—ADRBK1—lung—systemic scleroderma	0.0053	0.0417	CbGeAlD
Isoprenaline—Pallor—Leflunomide—systemic scleroderma	0.00523	0.0193	CcSEcCtD
Isoprenaline—MAPK1—lung—systemic scleroderma	0.00522	0.0411	CbGeAlD
Isoprenaline—Pallor—Mycophenolic acid—systemic scleroderma	0.00499	0.0184	CcSEcCtD
Isoprenaline—Bronchospasm—Pentoxifylline—systemic scleroderma	0.00428	0.0158	CcSEcCtD
Isoprenaline—Angina pectoris—Pentoxifylline—systemic scleroderma	0.00424	0.0157	CcSEcCtD
Isoprenaline—Pallor—Mycophenolate mofetil—systemic scleroderma	0.00393	0.0145	CcSEcCtD
Isoprenaline—Sweating—Pentoxifylline—systemic scleroderma	0.00372	0.0137	CcSEcCtD
Isoprenaline—Bronchospasm—Mometasone—systemic scleroderma	0.00369	0.0136	CcSEcCtD
Isoprenaline—Pulmonary oedema—Mycophenolic acid—systemic scleroderma	0.00368	0.0136	CcSEcCtD
Isoprenaline—ADRB1—connective tissue—systemic scleroderma	0.00367	0.0289	CbGeAlD
Isoprenaline—Cardiac arrest—Captopril—systemic scleroderma	0.00363	0.0134	CcSEcCtD
Isoprenaline—Pulmonary oedema—Lisinopril—systemic scleroderma	0.00331	0.0122	CcSEcCtD
Isoprenaline—Bronchospasm—Captopril—systemic scleroderma	0.00324	0.012	CcSEcCtD
Isoprenaline—Flushing—Pentoxifylline—systemic scleroderma	0.00323	0.0119	CcSEcCtD
Isoprenaline—Angina pectoris—Captopril—systemic scleroderma	0.00321	0.0119	CcSEcCtD
Isoprenaline—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00311	0.0115	CcSEcCtD
Isoprenaline—Tension—Pentoxifylline—systemic scleroderma	0.00298	0.011	CcSEcCtD
Isoprenaline—Nervousness—Pentoxifylline—systemic scleroderma	0.00294	0.0109	CcSEcCtD
Isoprenaline—Pulmonary oedema—Mycophenolate mofetil—systemic scleroderma	0.0029	0.0107	CcSEcCtD
Isoprenaline—Vision blurred—Pentoxifylline—systemic scleroderma	0.00286	0.0106	CcSEcCtD
Isoprenaline—Cardiac arrest—Mycophenolic acid—systemic scleroderma	0.00285	0.0105	CcSEcCtD
Isoprenaline—Tremor—Pentoxifylline—systemic scleroderma	0.00284	0.0105	CcSEcCtD
Isoprenaline—Palpitations—Pentoxifylline—systemic scleroderma	0.00268	0.0099	CcSEcCtD
Isoprenaline—Angina pectoris—Leflunomide—systemic scleroderma	0.00265	0.00978	CcSEcCtD
Isoprenaline—Convulsion—Pentoxifylline—systemic scleroderma	0.00263	0.00971	CcSEcCtD
Isoprenaline—Hypertension—Pentoxifylline—systemic scleroderma	0.00262	0.00967	CcSEcCtD
Isoprenaline—Cardiac arrest—Lisinopril—systemic scleroderma	0.00257	0.00949	CcSEcCtD
Isoprenaline—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.00253	0.00933	CcSEcCtD
Isoprenaline—Flushing—Captopril—systemic scleroderma	0.00245	0.00905	CcSEcCtD
Isoprenaline—Tachycardia—Pentoxifylline—systemic scleroderma	0.00242	0.00892	CcSEcCtD
Isoprenaline—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00239	0.00884	CcSEcCtD
Isoprenaline—Hypotension—Pentoxifylline—systemic scleroderma	0.00231	0.00854	CcSEcCtD
Isoprenaline—Bronchospasm—Lisinopril—systemic scleroderma	0.0023	0.00849	CcSEcCtD
Isoprenaline—Angina pectoris—Lisinopril—systemic scleroderma	0.00228	0.00841	CcSEcCtD
Isoprenaline—Tension—Captopril—systemic scleroderma	0.00225	0.00833	CcSEcCtD
Isoprenaline—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00832	CcSEcCtD
Isoprenaline—Insomnia—Pentoxifylline—systemic scleroderma	0.00224	0.00827	CcSEcCtD
Isoprenaline—Nervousness—Captopril—systemic scleroderma	0.00223	0.00825	CcSEcCtD
Isoprenaline—ADRB1—lung—systemic scleroderma	0.00222	0.0174	CbGeAlD
Isoprenaline—Sweating—Mycophenolic acid—systemic scleroderma	0.00222	0.00819	CcSEcCtD
Isoprenaline—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00221	0.00815	CcSEcCtD
Isoprenaline—Vision blurred—Captopril—systemic scleroderma	0.00217	0.008	CcSEcCtD
Isoprenaline—CYP1A1—skin of body—systemic scleroderma	0.00214	0.0168	CbGeAlD
Isoprenaline—Arrhythmia—Azathioprine—systemic scleroderma	0.00206	0.0076	CcSEcCtD
Isoprenaline—Palpitations—Captopril—systemic scleroderma	0.00203	0.0075	CcSEcCtD
Isoprenaline—Sweating—Lisinopril—systemic scleroderma	0.002	0.00738	CcSEcCtD
Isoprenaline—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00736	CcSEcCtD
Isoprenaline—Pulmonary oedema—Prednisone—systemic scleroderma	0.00197	0.00727	CcSEcCtD
Isoprenaline—Arrhythmia—Leflunomide—systemic scleroderma	0.00194	0.00718	CcSEcCtD
Isoprenaline—Dyspnoea—Mometasone—systemic scleroderma	0.0019	0.00703	CcSEcCtD
Isoprenaline—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00185	0.00685	CcSEcCtD
Isoprenaline—Tachycardia—Captopril—systemic scleroderma	0.00183	0.00676	CcSEcCtD
Isoprenaline—Vision blurred—Leflunomide—systemic scleroderma	0.00178	0.00659	CcSEcCtD
Isoprenaline—Asthenia—Pentoxifylline—systemic scleroderma	0.00178	0.00656	CcSEcCtD
Isoprenaline—Tension—Mycophenolic acid—systemic scleroderma	0.00177	0.00655	CcSEcCtD
Isoprenaline—Nervousness—Mycophenolic acid—systemic scleroderma	0.00175	0.00648	CcSEcCtD
Isoprenaline—Hypotension—Captopril—systemic scleroderma	0.00175	0.00647	CcSEcCtD
Isoprenaline—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00646	CcSEcCtD
Isoprenaline—Flushing—Lisinopril—systemic scleroderma	0.00173	0.00641	CcSEcCtD
Isoprenaline—CYP1A1—digestive system—systemic scleroderma	0.00171	0.0135	CbGeAlD
Isoprenaline—Vision blurred—Mycophenolic acid—systemic scleroderma	0.0017	0.00629	CcSEcCtD
Isoprenaline—Vertigo—Leflunomide—systemic scleroderma	0.0017	0.00629	CcSEcCtD
Isoprenaline—Insomnia—Captopril—systemic scleroderma	0.0017	0.00627	CcSEcCtD
Isoprenaline—Tremor—Mycophenolic acid—systemic scleroderma	0.00169	0.00625	CcSEcCtD
Isoprenaline—Palpitations—Leflunomide—systemic scleroderma	0.00167	0.00618	CcSEcCtD
Isoprenaline—Dyspnoea—Captopril—systemic scleroderma	0.00167	0.00618	CcSEcCtD
Isoprenaline—Arrhythmia—Lisinopril—systemic scleroderma	0.00167	0.00617	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00164	0.00608	CcSEcCtD
Isoprenaline—Dizziness—Pentoxifylline—systemic scleroderma	0.00164	0.00605	CcSEcCtD
Isoprenaline—Hypertension—Leflunomide—systemic scleroderma	0.00164	0.00604	CcSEcCtD
Isoprenaline—Vertigo—Mycophenolic acid—systemic scleroderma	0.00162	0.006	CcSEcCtD
Isoprenaline—Tension—Lisinopril—systemic scleroderma	0.0016	0.0059	CcSEcCtD
Isoprenaline—Palpitations—Mycophenolic acid—systemic scleroderma	0.0016	0.0059	CcSEcCtD
Isoprenaline—Nervousness—Lisinopril—systemic scleroderma	0.00158	0.00584	CcSEcCtD
Isoprenaline—Convulsion—Mycophenolic acid—systemic scleroderma	0.00157	0.00578	CcSEcCtD
Isoprenaline—Hypertension—Mycophenolic acid—systemic scleroderma	0.00156	0.00576	CcSEcCtD
Isoprenaline—Headache—Pentoxifylline—systemic scleroderma	0.00155	0.00573	CcSEcCtD
Isoprenaline—Vision blurred—Lisinopril—systemic scleroderma	0.00153	0.00567	CcSEcCtD
Isoprenaline—Asthenia—Mometasone—systemic scleroderma	0.00153	0.00566	CcSEcCtD
Isoprenaline—Hypotension—Azathioprine—systemic scleroderma	0.00153	0.00565	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisone—systemic scleroderma	0.00153	0.00564	CcSEcCtD
Isoprenaline—Tremor—Lisinopril—systemic scleroderma	0.00152	0.00563	CcSEcCtD
Isoprenaline—Tachycardia—Leflunomide—systemic scleroderma	0.00151	0.00557	CcSEcCtD
Isoprenaline—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00149	0.00552	CcSEcCtD
Isoprenaline—Nausea—Pentoxifylline—systemic scleroderma	0.00147	0.00543	CcSEcCtD
Isoprenaline—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00541	CcSEcCtD
Isoprenaline—Vertigo—Lisinopril—systemic scleroderma	0.00146	0.0054	CcSEcCtD
Isoprenaline—Hypotension—Leflunomide—systemic scleroderma	0.00144	0.00534	CcSEcCtD
Isoprenaline—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00144	0.00532	CcSEcCtD
Isoprenaline—Palpitations—Lisinopril—systemic scleroderma	0.00144	0.00531	CcSEcCtD
Isoprenaline—CYP1A1—lung—systemic scleroderma	0.00143	0.0112	CbGeAlD
Isoprenaline—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00143	0.00527	CcSEcCtD
Isoprenaline—Tension—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00517	CcSEcCtD
Isoprenaline—Insomnia—Leflunomide—systemic scleroderma	0.0014	0.00517	CcSEcCtD
Isoprenaline—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00512	CcSEcCtD
Isoprenaline—Dyspnoea—Leflunomide—systemic scleroderma	0.00138	0.00509	CcSEcCtD
Isoprenaline—Hypotension—Mycophenolic acid—systemic scleroderma	0.00138	0.00509	CcSEcCtD
Isoprenaline—Asthenia—Captopril—systemic scleroderma	0.00135	0.00497	CcSEcCtD
Isoprenaline—Headache—Mometasone—systemic scleroderma	0.00134	0.00494	CcSEcCtD
Isoprenaline—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00494	CcSEcCtD
Isoprenaline—Insomnia—Mycophenolic acid—systemic scleroderma	0.00133	0.00493	CcSEcCtD
Isoprenaline—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00131	0.00486	CcSEcCtD
Isoprenaline—Tachycardia—Lisinopril—systemic scleroderma	0.0013	0.00479	CcSEcCtD
Isoprenaline—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00128	0.00474	CcSEcCtD
Isoprenaline—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00473	CcSEcCtD
Isoprenaline—Nausea—Mometasone—systemic scleroderma	0.00127	0.00469	CcSEcCtD
Isoprenaline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00466	CcSEcCtD
Isoprenaline—Hypotension—Lisinopril—systemic scleroderma	0.00124	0.00459	CcSEcCtD
Isoprenaline—Dizziness—Captopril—systemic scleroderma	0.00124	0.00458	CcSEcCtD
Isoprenaline—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00456	CcSEcCtD
Isoprenaline—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00455	CcSEcCtD
Isoprenaline—Insomnia—Lisinopril—systemic scleroderma	0.0012	0.00444	CcSEcCtD
Isoprenaline—Dyspnoea—Lisinopril—systemic scleroderma	0.00118	0.00437	CcSEcCtD
Isoprenaline—Headache—Captopril—systemic scleroderma	0.00117	0.00434	CcSEcCtD
Isoprenaline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00114	0.0042	CcSEcCtD
Isoprenaline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00416	CcSEcCtD
Isoprenaline—Nausea—Captopril—systemic scleroderma	0.00111	0.00412	CcSEcCtD
Isoprenaline—Asthenia—Leflunomide—systemic scleroderma	0.00111	0.0041	CcSEcCtD
Isoprenaline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00402	CcSEcCtD
Isoprenaline—Dizziness—Azathioprine—systemic scleroderma	0.00108	0.004	CcSEcCtD
Isoprenaline—Asthenia—Mycophenolic acid—systemic scleroderma	0.00106	0.00391	CcSEcCtD
Isoprenaline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00389	CcSEcCtD
Isoprenaline—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00383	CcSEcCtD
Isoprenaline—Flushing—Prednisone—systemic scleroderma	0.00103	0.00381	CcSEcCtD
Isoprenaline—Headache—Azathioprine—systemic scleroderma	0.00103	0.00379	CcSEcCtD
Isoprenaline—Dizziness—Leflunomide—systemic scleroderma	0.00102	0.00378	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—systemic scleroderma	0.000992	0.00366	CcSEcCtD
Isoprenaline—Sweating—Methotrexate—systemic scleroderma	0.000991	0.00366	CcSEcCtD
Isoprenaline—Dizziness—Mycophenolic acid—systemic scleroderma	0.000975	0.0036	CcSEcCtD
Isoprenaline—Nausea—Azathioprine—systemic scleroderma	0.000972	0.00359	CcSEcCtD
Isoprenaline—Headache—Leflunomide—systemic scleroderma	0.000968	0.00358	CcSEcCtD
Isoprenaline—Asthenia—Lisinopril—systemic scleroderma	0.000953	0.00352	CcSEcCtD
Isoprenaline—Headache—Mycophenolic acid—systemic scleroderma	0.000924	0.00341	CcSEcCtD
Isoprenaline—Nausea—Leflunomide—systemic scleroderma	0.000918	0.00339	CcSEcCtD
Isoprenaline—Vision blurred—Prednisone—systemic scleroderma	0.000911	0.00337	CcSEcCtD
Isoprenaline—Dizziness—Lisinopril—systemic scleroderma	0.000878	0.00324	CcSEcCtD
Isoprenaline—Nausea—Mycophenolic acid—systemic scleroderma	0.000876	0.00324	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—systemic scleroderma	0.000868	0.00321	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—systemic scleroderma	0.000837	0.00309	CcSEcCtD
Isoprenaline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000835	0.00308	CcSEcCtD
Isoprenaline—Hypertension—Prednisone—systemic scleroderma	0.000834	0.00308	CcSEcCtD
Isoprenaline—Headache—Lisinopril—systemic scleroderma	0.000832	0.00307	CcSEcCtD
Isoprenaline—Nausea—Lisinopril—systemic scleroderma	0.000789	0.00291	CcSEcCtD
Isoprenaline—Tachycardia—Prednisone—systemic scleroderma	0.00077	0.00284	CcSEcCtD
Isoprenaline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00077	0.00284	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—systemic scleroderma	0.000763	0.00282	CcSEcCtD
Isoprenaline—Vision blurred—Methotrexate—systemic scleroderma	0.000761	0.00281	CcSEcCtD
Isoprenaline—Headache—Mycophenolate mofetil—systemic scleroderma	0.000729	0.00269	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—systemic scleroderma	0.000726	0.00268	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—systemic scleroderma	0.000713	0.00264	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—systemic scleroderma	0.0007	0.00259	CcSEcCtD
Isoprenaline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000691	0.00255	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000637	0.00235	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—systemic scleroderma	0.000616	0.00228	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—systemic scleroderma	0.000596	0.0022	CcSEcCtD
Isoprenaline—Dyspnoea—Methotrexate—systemic scleroderma	0.000588	0.00217	CcSEcCtD
Isoprenaline—Asthenia—Prednisone—systemic scleroderma	0.000566	0.00209	CcSEcCtD
Isoprenaline—Dizziness—Prednisone—systemic scleroderma	0.000522	0.00193	CcSEcCtD
Isoprenaline—Headache—Prednisone—systemic scleroderma	0.000494	0.00183	CcSEcCtD
Isoprenaline—Asthenia—Methotrexate—systemic scleroderma	0.000473	0.00175	CcSEcCtD
Isoprenaline—Nausea—Prednisone—systemic scleroderma	0.000469	0.00173	CcSEcCtD
Isoprenaline—Dizziness—Methotrexate—systemic scleroderma	0.000436	0.00161	CcSEcCtD
Isoprenaline—Headache—Methotrexate—systemic scleroderma	0.000413	0.00153	CcSEcCtD
Isoprenaline—Nausea—Methotrexate—systemic scleroderma	0.000392	0.00145	CcSEcCtD
Isoprenaline—MAPK1—Hemostasis—ITGAM—systemic scleroderma	0.00029	0.000481	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—IL1A—systemic scleroderma	0.000289	0.00048	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CSK—systemic scleroderma	0.000289	0.00048	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IRF5—systemic scleroderma	0.000289	0.00048	CbGpPWpGaD
Isoprenaline—MAPK1—Spinal Cord Injury—IL1B—systemic scleroderma	0.000287	0.000477	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—RHOB—systemic scleroderma	0.000286	0.000475	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFBI—systemic scleroderma	0.000285	0.000473	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IRF5—systemic scleroderma	0.000284	0.000472	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000284	0.000472	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—HSPG2—systemic scleroderma	0.000281	0.000466	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—CTLA4—systemic scleroderma	0.000279	0.000464	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—RHOB—systemic scleroderma	0.000279	0.000463	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—EDN1—systemic scleroderma	0.000278	0.000461	CbGpPWpGaD
Isoprenaline—MAPK1—TCR Signaling Pathway—TGFB1—systemic scleroderma	0.000277	0.00046	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—HSPG2—systemic scleroderma	0.000276	0.000459	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD247—systemic scleroderma	0.000276	0.000458	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—ITGAM—systemic scleroderma	0.000276	0.000458	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IRF8—systemic scleroderma	0.000276	0.000458	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	0.000276	0.000458	CbGpPWpGaD
Isoprenaline—MAPK1—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	0.000272	0.000452	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IRF8—systemic scleroderma	0.000272	0.000451	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD247—systemic scleroderma	0.000272	0.000451	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—ITGAM—systemic scleroderma	0.000272	0.000451	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CSK—systemic scleroderma	0.000271	0.00045	CbGpPWpGaD
Isoprenaline—MAPK1—Spinal Cord Injury—MMP9—systemic scleroderma	0.000271	0.00045	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—SMAD7—systemic scleroderma	0.000269	0.000447	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—CD40LG—systemic scleroderma	0.000268	0.000445	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CSK—systemic scleroderma	0.000267	0.000443	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—SMAD7—systemic scleroderma	0.000265	0.000441	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—MMP1—systemic scleroderma	0.000264	0.000438	CbGpPWpGaD
Isoprenaline—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000263	0.000437	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CTLA4—systemic scleroderma	0.000262	0.000436	CbGpPWpGaD
Isoprenaline—MAPK1—EGF/EGFR Signaling Pathway—NOS3—systemic scleroderma	0.000262	0.000435	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—RHOB—systemic scleroderma	0.000261	0.000434	CbGpPWpGaD
Isoprenaline—PIK3R2—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	0.000261	0.000434	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CD247—systemic scleroderma	0.000261	0.000433	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—ITGAM—systemic scleroderma	0.000261	0.000433	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—TNFAIP3—systemic scleroderma	0.000258	0.000429	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—BLK—systemic scleroderma	0.000255	0.000424	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CD247—systemic scleroderma	0.000255	0.000423	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—TNFAIP3—systemic scleroderma	0.000255	0.000423	CbGpPWpGaD
Isoprenaline—MAPK1—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	0.000252	0.000418	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—BLK—systemic scleroderma	0.000252	0.000418	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CD247—systemic scleroderma	0.000251	0.000417	CbGpPWpGaD
Isoprenaline—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000249	0.000414	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—EDN1—systemic scleroderma	0.000249	0.000413	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HSPG2—systemic scleroderma	0.000247	0.000409	CbGpPWpGaD
Isoprenaline—PIK3R2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000245	0.000407	CbGpPWpGaD
Isoprenaline—MAPK1—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	0.000245	0.000407	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—TNFAIP3—systemic scleroderma	0.000244	0.000406	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—NOS3—systemic scleroderma	0.00024	0.000398	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CSK—systemic scleroderma	0.000238	0.000395	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CSK—systemic scleroderma	0.000238	0.000395	CbGpPWpGaD
Isoprenaline—MAPK1—DNA Damage Response (only ATM dependent)—TGFB1—systemic scleroderma	0.000238	0.000395	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—HSPG2—systemic scleroderma	0.000235	0.00039	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by SCF-KIT—MMP9—systemic scleroderma	0.000235	0.00039	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IRF5—systemic scleroderma	0.000234	0.000389	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.00023	0.000382	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HSPG2—systemic scleroderma	0.000227	0.000378	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—EDN1—systemic scleroderma	0.000226	0.000375	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ITGAM—systemic scleroderma	0.000224	0.000371	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD247—systemic scleroderma	0.000224	0.000371	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IRF8—systemic scleroderma	0.000224	0.000371	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—CTGF—systemic scleroderma	0.000223	0.000371	CbGpPWpGaD
Isoprenaline—MAPK1—Spinal Cord Injury—TGFB1—systemic scleroderma	0.000223	0.000371	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CSK—systemic scleroderma	0.00022	0.000365	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SMAD7—systemic scleroderma	0.000218	0.000362	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—CD40LG—systemic scleroderma	0.000217	0.000361	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—IL1B—systemic scleroderma	0.000217	0.000359	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.000216	0.000359	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—HLA-DQB1—systemic scleroderma	0.000216	0.000359	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—MMP1—systemic scleroderma	0.000214	0.000355	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SMAD7—systemic scleroderma	0.000213	0.000354	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SMAD7—systemic scleroderma	0.000212	0.000352	CbGpPWpGaD
Isoprenaline—PIK3R1—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	0.000212	0.000351	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.000212	0.000351	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—TNFAIP3—systemic scleroderma	0.000209	0.000348	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CTLA4—systemic scleroderma	0.000209	0.000347	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—RHOB—systemic scleroderma	0.000208	0.000346	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—BLK—systemic scleroderma	0.000207	0.000344	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CD247—systemic scleroderma	0.000206	0.000343	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CTLA4—systemic scleroderma	0.000206	0.000342	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—RHOB—systemic scleroderma	0.000205	0.000341	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL1A—systemic scleroderma	0.000205	0.000341	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CD40LG—systemic scleroderma	0.000204	0.000339	CbGpPWpGaD
Isoprenaline—MAPK1—TGF-beta Signaling Pathway—TGFB1—systemic scleroderma	0.000204	0.000339	CbGpPWpGaD
Isoprenaline—PIK3R1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000199	0.00033	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—EDN1—systemic scleroderma	0.000198	0.000329	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HSPG2—systemic scleroderma	0.000197	0.000326	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—EDN1—systemic scleroderma	0.000195	0.000324	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—RHOB—systemic scleroderma	0.000194	0.000323	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFBI—systemic scleroderma	0.000194	0.000322	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HSPG2—systemic scleroderma	0.000194	0.000321	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—NOS3—systemic scleroderma	0.000191	0.000318	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—HSPG2—systemic scleroderma	0.00019	0.000316	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CSK—systemic scleroderma	0.00019	0.000315	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—CCL2—systemic scleroderma	0.00019	0.000315	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CSK—systemic scleroderma	0.000187	0.00031	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—RHOB—systemic scleroderma	0.000182	0.000303	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—EDN1—systemic scleroderma	0.00018	0.000299	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—RHOB—systemic scleroderma	0.000178	0.000296	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—CTGF—systemic scleroderma	0.000178	0.000296	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—EDN1—systemic scleroderma	0.000177	0.000295	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—HLA-DQB1—systemic scleroderma	0.000172	0.000286	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—HLA-DQB1—systemic scleroderma	0.00017	0.000282	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CTLA4—systemic scleroderma	0.000169	0.000281	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—RHOB—systemic scleroderma	0.000169	0.00028	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TGFB1—systemic scleroderma	0.000168	0.000279	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—RHOB—systemic scleroderma	0.000166	0.000275	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—RHOB—systemic scleroderma	0.000165	0.000274	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—EDN1—systemic scleroderma	0.000165	0.000274	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1A—systemic scleroderma	0.000164	0.000272	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD40LG—systemic scleroderma	0.000163	0.00027	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—RHOB—systemic scleroderma	0.000162	0.000269	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CSK—systemic scleroderma	0.000162	0.000268	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000161	0.000268	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1A—systemic scleroderma	0.000161	0.000268	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—EDN1—systemic scleroderma	0.000161	0.000268	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—EDN1—systemic scleroderma	0.000161	0.000267	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—MMP2—systemic scleroderma	0.000161	0.000267	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD40LG—systemic scleroderma	0.00016	0.000266	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HSPG2—systemic scleroderma	0.000159	0.000264	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IRF5—systemic scleroderma	0.000159	0.000264	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—TGFB1—systemic scleroderma	0.000159	0.000263	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—EDN1—systemic scleroderma	0.000157	0.00026	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HSPG2—systemic scleroderma	0.000155	0.000258	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—NOS3—systemic scleroderma	0.000155	0.000257	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HSPG2—systemic scleroderma	0.000155	0.000257	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—CCL2—systemic scleroderma	0.000154	0.000256	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CSK—systemic scleroderma	0.000154	0.000255	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IRF8—systemic scleroderma	0.000152	0.000252	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ITGAM—systemic scleroderma	0.000152	0.000252	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD247—systemic scleroderma	0.000152	0.000252	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	0.000152	0.000252	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CSK—systemic scleroderma	0.00015	0.000249	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CSK—systemic scleroderma	0.000149	0.000248	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SMAD7—systemic scleroderma	0.000148	0.000246	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000148	0.000246	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—EDN1—systemic scleroderma	0.000146	0.000242	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—MMP1—systemic scleroderma	0.000145	0.000241	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000145	0.00024	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—CTGF—systemic scleroderma	0.000144	0.00024	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	0.000144	0.000239	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—EDN1—systemic scleroderma	0.000142	0.000237	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TNFAIP3—systemic scleroderma	0.000142	0.000236	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—BLK—systemic scleroderma	0.000141	0.000234	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD247—systemic scleroderma	0.00014	0.000233	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HLA-DQB1—systemic scleroderma	0.00014	0.000232	CbGpPWpGaD
Isoprenaline—MAPK1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000135	0.000224	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EDN1—systemic scleroderma	0.000133	0.000222	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1A—systemic scleroderma	0.000133	0.00022	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD40LG—systemic scleroderma	0.000132	0.000219	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SMAD7—systemic scleroderma	0.000126	0.00021	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TGFB1—systemic scleroderma	0.000126	0.00021	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SMAD7—systemic scleroderma	0.000124	0.000205	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—CCL2—systemic scleroderma	0.000123	0.000204	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000122	0.000203	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—CCL2—systemic scleroderma	0.000121	0.000201	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—MMP9—systemic scleroderma	0.000121	0.0002	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—NOS3—systemic scleroderma	0.000116	0.000193	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CTLA4—systemic scleroderma	0.000115	0.000191	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RHOB—systemic scleroderma	0.000115	0.000191	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP2—systemic scleroderma	0.000115	0.00019	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—CCL2—systemic scleroderma	0.000113	0.000187	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—CCL2—systemic scleroderma	0.00011	0.000183	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HSPG2—systemic scleroderma	0.000108	0.00018	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL1B—systemic scleroderma	0.000107	0.000178	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EDN1—systemic scleroderma	0.000106	0.000177	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—NOS3—systemic scleroderma	0.000105	0.000175	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EDN1—systemic scleroderma	0.000105	0.000174	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CSK—systemic scleroderma	0.000105	0.000174	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TGFB1—systemic scleroderma	0.000102	0.00017	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CCL2—systemic scleroderma	9.98e-05	0.000166	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EDN1—systemic scleroderma	9.92e-05	0.000165	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RHOB—systemic scleroderma	9.78e-05	0.000162	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CCL2—systemic scleroderma	9.74e-05	0.000162	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—NOS3—systemic scleroderma	9.73e-05	0.000161	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RHOB—systemic scleroderma	9.57e-05	0.000159	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-DQB1—systemic scleroderma	9.49e-05	0.000158	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—EDN1—systemic scleroderma	9.31e-05	0.000155	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—NOS3—systemic scleroderma	9.26e-05	0.000154	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HSPG2—systemic scleroderma	9.22e-05	0.000153	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CCL2—systemic scleroderma	9.12e-05	0.000152	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—NOS3—systemic scleroderma	9.12e-05	0.000151	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—EDN1—systemic scleroderma	9.11e-05	0.000151	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HSPG2—systemic scleroderma	9.02e-05	0.00015	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1A—systemic scleroderma	9.01e-05	0.00015	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD40LG—systemic scleroderma	8.96e-05	0.000149	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CSK—systemic scleroderma	8.91e-05	0.000148	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CSK—systemic scleroderma	8.71e-05	0.000145	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EDN1—systemic scleroderma	8.62e-05	0.000143	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP9—systemic scleroderma	8.61e-05	0.000143	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1B—systemic scleroderma	8.53e-05	0.000142	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EDN1—systemic scleroderma	8.45e-05	0.00014	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EDN1—systemic scleroderma	8.41e-05	0.00014	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1B—systemic scleroderma	8.4e-05	0.00014	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EDN1—systemic scleroderma	8.27e-05	0.000137	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NOS3—systemic scleroderma	8.13e-05	0.000135	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—NOS3—systemic scleroderma	7.75e-05	0.000129	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—TGFB1—systemic scleroderma	7.68e-05	0.000128	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NOS3—systemic scleroderma	7.5e-05	0.000125	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CCL2—systemic scleroderma	7.27e-05	0.000121	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HSPG2—systemic scleroderma	7.18e-05	0.000119	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CCL2—systemic scleroderma	7.16e-05	0.000119	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TGFB1—systemic scleroderma	7.1e-05	0.000118	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TGFB1—systemic scleroderma	6.96e-05	0.000116	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1B—systemic scleroderma	6.91e-05	0.000115	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCL2—systemic scleroderma	6.78e-05	0.000113	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—systemic scleroderma	6.53e-05	0.000108	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NOS3—systemic scleroderma	6.48e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NOS3—systemic scleroderma	6.39e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—NOS3—systemic scleroderma	6.28e-05	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—TGFB1—systemic scleroderma	6.12e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—TGFB1—systemic scleroderma	6.03e-05	0.0001	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL2—systemic scleroderma	5.89e-05	9.79e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EDN1—systemic scleroderma	5.86e-05	9.73e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL2—systemic scleroderma	5.78e-05	9.6e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL2—systemic scleroderma	5.75e-05	9.55e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL2—systemic scleroderma	5.65e-05	9.39e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CTGF—systemic scleroderma	5.44e-05	9.04e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFB1—systemic scleroderma	5.38e-05	8.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOS3—systemic scleroderma	5.25e-05	8.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—systemic scleroderma	5.2e-05	8.64e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOS3—systemic scleroderma	5.13e-05	8.51e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—systemic scleroderma	5.12e-05	8.51e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS3—systemic scleroderma	5.1e-05	8.47e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EDN1—systemic scleroderma	4.99e-05	8.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—systemic scleroderma	4.96e-05	8.24e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EDN1—systemic scleroderma	4.89e-05	8.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—systemic scleroderma	4.7e-05	7.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—systemic scleroderma	4.29e-05	7.12e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—systemic scleroderma	4.22e-05	7.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—systemic scleroderma	4.21e-05	7e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—systemic scleroderma	4.11e-05	6.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—systemic scleroderma	4.01e-05	6.65e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—systemic scleroderma	3.57e-05	5.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—systemic scleroderma	3.47e-05	5.77e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—systemic scleroderma	3.41e-05	5.67e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—systemic scleroderma	3.39e-05	5.63e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—systemic scleroderma	3.37e-05	5.6e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—systemic scleroderma	3.34e-05	5.55e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—systemic scleroderma	3.04e-05	5.05e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—systemic scleroderma	2.98e-05	4.94e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—systemic scleroderma	2.86e-05	4.76e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—systemic scleroderma	2.44e-05	4.05e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—systemic scleroderma	2.39e-05	3.97e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—systemic scleroderma	2.37e-05	3.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—systemic scleroderma	2.36e-05	3.92e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—systemic scleroderma	2.01e-05	3.34e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—systemic scleroderma	1.97e-05	3.27e-05	CbGpPWpGaD
